Results 21 to 30 of about 5,318 (180)

A Case of Sebaceous Adenitis and Concurrent Meibomian Gland Dysfunction in a Dog

open access: yesVeterinary Sciences, 2020
Sebaceous adenitis and concurrent meibomian gland dysfunction (MGD) were diagnosed in a two-year-old mongrel dog presenting with hypotrichosis, exfoliative dermatitis and blepharitis.
Roberta Sartori, Claudio Peruccio
doaj   +1 more source

Dupilumab-Associated Blepharoconjunctivitis: Clinical and Morphological Aspects

open access: yesBiomedicines, 2023
Purpose: To describe the clinical and morphologic changes in the ocular surface microstructure of patients affected with moderate-to-severe Atopic Dermatitis (AD) before and during Dupilumab treatment.
Federica Serino   +7 more
doaj   +1 more source

Meibomian Gland Morphology Is a Sensitive Early Indicator of Meibomian Gland Dysfunction [PDF]

open access: yesAmerican Journal of Ophthalmology, 2019
To investigate the relationship between meibomian gland (MG) morphology and clinical dry eye tests in patients with meibomian gland dysfunction (MGD).Cross-sectional study.Total 538 MGD patients and 21 healthy controls.MG loss on meibography images of upper (UL) and lower lids (LL) was graded on a scale of 0 (lowest degree of MG loss) to 3.
Muhammed Yasin Adil   +8 more
openaire   +4 more sources

Noncontact Meibography in Patients with Keratoconus

open access: yesJournal of Ophthalmology, 2019
Purpose. To examine the morphological changes in the meibomian glands of patients with keratoconus as well as to study the relationship between these changes in the morphology and several tear film parameters. Methods. Examination of the meibomian gland (
Engy Mohamed Mostafa   +3 more
doaj   +1 more source

Repeatability of Meibomian Gland Contrast, a Potential Indicator of Meibomian Gland Function [PDF]

open access: yesCornea, 2018
Purpose: Meibomian gland contrast may be a potential indicator of gland health, especially among isotretinoin users. We aimed to develop a repeatable and reliable method for measuring Meibomian gland contrast from meibography images.
Yeh, Thao N, Lin, Meng C
openaire   +4 more sources

Modern Ideas about Dysfunction of the Meibomian Glands

open access: yesOftalʹmologiâ, 2022
Purpose: to develop a comprehensive method of meibomian gland dysfunction (MGD) treatment, including the periorbital zone massage, aimed to improving the microcirculation of the eyelids and the functional activity of the meibomian glands, evaluating its ...
I. B. Medvedev   +6 more
doaj   +1 more source

Outcome parameters in studies investigating dry eye disease: A systematic literature review

open access: yesActa Ophthalmologica, EarlyView.
Abstract The development of effective therapeutics for dry eye disease (DED) is challenging due to its complex pathophysiology, heterogeneous patient presentation and the significant failure rate of previous clinical development programs. This underlines the importance of the selection of appropriate endpoints for clinical trials.
Viktoria Pai   +8 more
wiley   +1 more source

Could Ocular Glands Be Infected by SARS-CoV-2?

open access: yesDiseases
The aim of the study was to investigate the expression levels of ACE2 in ocular glands and to investigate the effect of S protein on them. Male C57BL/6J mice were used for the experiments. The expression levels of ACE2 are highest in the Meibomian glands,
Jinghua Bu   +5 more
doaj   +1 more source

Characteristics of tear film lipid layer in young dry eye patients

open access: yesJournal of the Formosan Medical Association, 2021
Background/Purpose: To investigate the characteristics of subjective symptoms and objective parameters among young patients with dry eye disease (DED) and compare them with those of older patients.
Hsin-Yu Weng   +4 more
doaj   +1 more source

What is the incidence and clinical significance of dry eye disease in patients treated with immune checkpoint inhibitors? A systematic review and meta‐analysis of ocular immune‐related adverse events

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but may cause immune‐related adverse events (irAEs), including dry eye disease (DED). This study aimed to quantify the incidence of ICI‐associated DED and to evaluate factors contributing to variability across studies.
Kai‐Yang Chen   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy